FindTrial
Sign In

Impact of Novel Coronavirus Pneumonia (COVID-19) Epidemic Period on the Management of investigator-initiated clinical trial and the resilience of medical service providers

Impact of Novel Coronavirus Pneumonia (COVID-19) Epidemic Period on the Management of investigator-initiated clinical trial and the resilience of medical service providers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030757
Enrollment
Unknown
Registered
2020-03-13
Start date
2020-03-13
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

Case series:Nil

Sponsors

Clinical Research Institute, Shenzhen-Peking University-The Hong Kong University of Science & Technology Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Currently participating in or responsible for an investigator-initiated clinical trial; (2) Voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Psychological assessment;—

Secondary

MeasureTime frame
project management;—

Countries

China

Contacts

Public ContactZhang Yue

Clinical Research Institute, Shenzhen-Peking University-The Hong Kong University of Science & Technology Medical Center

zyzy1933@163.com+86 18823361933

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026